Clinical Trials Directory

Trials / Completed

CompletedNCT04602286

How Does Mindfulness Meditation Buffer the Negative Effects of Pain and Suffering in the COVID-19 World? (Pain Sample)

An Online Randomized Controlled Trial Comparing the Effects of Mindfulness, Sham Mindfulness and Book Listening Control on Pain Experience in Adults With Recurrent and Chronic Pain

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
373 (actual)
Sponsor
The University of Queensland · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Both mindfulness meditation and expectancy effects are known to reduce pain intensity, pain unpleasantness and pain catastrophizing, but it is unknown whether and how expectancy effects contribute to the overall effect of mindfulness meditation on these outcomes, especially during significant global events such as the coronavirus pandemic. This study includes four interrelated aims that will probe these effects and interactions.

Detailed description

As many as 1 in 4 Australians experience chronic pain. Further, it is yet unknown the effects of the Coronavirus (COVID-19) pandemic on Australians with or at risk of chronic pain. There is a critical need for the development and evaluation of fast-acting non-pharmaceutical treatments that have the capacity to target the multidimensional nature of chronic pain. This study will investigate how mindfulness meditation and common expectancy effects interact and will further characterise the mechanisms underlying these effects. Results will ultimately lead to targeted interventions that more effectively engage cognitive mechanisms associated with pain attenuation.

Conditions

Interventions

TypeNameDescription
OTHERMeditation (1 x 20-minute guided audio training)Participants will complete a single session of 20-minutes online guided audio-delivered training session of one of the four conditions.

Timeline

Start date
2020-10-28
Primary completion
2021-09-28
Completion
2021-09-28
First posted
2020-10-26
Last updated
2023-02-17

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT04602286. Inclusion in this directory is not an endorsement.